Ziarco
is a developer of therapeutic agents for the treatment of chronic inflammatory skin disorders such as atopic dermatitis and psoriasis... Read moreZiarco
is a developer of therapeutic agents for the treatment of chronic inflammatory skin disorders such as atopic dermatitis and psoriasis... Read more
News
Apr 11, 2017
BioPortfolio
Ziarco: Ziarco Pharma Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Updated 27022017 Prices from USD $250
Feb 27, 2017
BioPortfolio
Ziarco: Ziarco Pharma Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Updated 19122016 Prices from USD $250
Jan 31, 2017
The Pharma Letter
Ziarco: Anacor, Ziarco...could Realm be the next hot property in dermatology?
Dec 16, 2016
GlobalNewswire
Press Release: Ziarco : Novartis bolsters innovative dermatology portfolio through acquisition of Ziarco Group Limited
Dec 16, 2016
BioPortfolio
Ziarco: Novartis Buys Ziarco to Gain Experimental Eczema Treatment
Jun 15, 2016
BioSpace
Ziarco: Pfizer-Backed Ziarco Exploring Sale, Deal Could Bring in $1 Billion+
Jun 13, 2016
BioPortfolio
Ziarco: Ziarco Pharma Ltd Ziarco reports positive Phase 2a study results with ZPL389 in moderate to severe atopic dermatitis patients
May 16, 2016
BioPortfolio
Ziarco: Ziarco Pharma Announces Positive Top Line Results from Phase 2a Study in Moderate to Severe Atopic Dermatitis with its Oral Lead Compound ZPL389
Feb 28, 2016
BioSpace
Ziarco: Ziarco Release: Appointment Of Dr. As Chief Business Officer
Feb 25, 2016
PR-Inside
Press Release: Ziarco : Ziarco Pharma Ltd - Product Pipeline Review - 2015 - New Market Report
Ziarco Competitors
1
2
3
4
5
6
7
8